Filing Details
- Accession Number:
- 0000805928-23-000106
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-25 16:16:36
- Reporting Period:
- 2023-08-23
- Accepted Time:
- 2023-08-25 16:16:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 805928 | Axogen Inc. | AXGN | Electromedical & Electrotherapeutic Apparatus (3845) | 411301878 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1682069 | Mr. P. William Burke | C/O Axogen, Inc. 13631 Progress Blvd., Suite 400 Alachua FL 32615 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-08-23 | 10,000 | $6.56 | 10,000 | No | 4 | P | Indirect | By Spouse |
| Common Stock | Acquisiton | 2023-08-24 | 6,000 | $6.31 | 6,000 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Spouse |
| No | 4 | A | Direct |
Footnotes
- The reported price in Column 4 is a weighted average purchase price. These shares were purchased in several transactions at prices ranging from $6.54 to $6.57 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $6.28 to $6.35 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
